Estimated Cost-effectiveness of Subcutaneous Insulin Aspart in the Management of Mild Diabetic Ketoacidosis Among Children

Authors:

Abstract
Diabetic ketoacidosis (DKA) remains a leading cause of hospitalization among children with type 1 diabetes in Saudi Arabia and worldwide.1-5 Typically, its treatment requires intravenous (IV) regular insulin infusion and close clinical monitoring6 at a pediatric intensive care unit (ICU) or at a high-dependency unit setting, causing a burden on health care systems to accommodate other more acutely sick children.7-10 Use of health care resources is an important aspect of DKA management, especially in situations for which the standard-of-care management and monitoring facilities are not readily available either owing to limited health care resources or during epidemics.6,7,10

This publication has 35 references indexed in Scilit: